News Articles for William Dolphin

Avita falls on UK delay

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Shares in Avita Medical have hit a 2014 low following the company's announcement efforts to commercialise in the UK have hit a snag.

Avita announces major trial changes

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Perth biotechnology firm Avita Medical has announced major changes to a clinical trial in the US it hopes will improve shareholder confidence.

Biotechs bleed cash in search for profit

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

WA biotechs are drowning in a sea of red as yet more negative results are reported.

Avita Medical reveals new chairman

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Biotech company Avita Medical has appointed a new chairman after shareholder outrage against the company's remuneration report last year claimed the scalp of former chairman Dalton Gooding.

Dolphin steps down as Avita CEO

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

William Dolphin has agreed to step down as chief executive of biotech company Avita Medical, and Dalton Gooding has resigned after announcing his intention to do so at the company's annual general meeting in November.

Investors cut CEOs some slack

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

FEATURE: It has been a difficult year for many of WA's listed entities, but investors are backing the performance of most of the state's top executives.

Gooding to step down after huge ‘no’ vote

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Dalton Gooding has agreed to stand down as chairman of biotech company Avita Medical but shareholders today supported the re-elect

Visiomed takes major step into US market

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Nedlands-based Visiomed Group Ltd has secured United States FDA clearance for its redesigned and improved 'Funhaler' paediatric asthma incentive spacer.